Aromando Andrew 4
4 · Ambrx Biopharma Inc. · Filed Jul 7, 2023
Insider Transaction Report
Form 4
Aromando Andrew
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2023-07-05+389,000→ 389,000 totalExercise: $2.38Exp: 2033-07-05→ Ordinary Shares (389,000 underlying)
Footnotes (3)
- [F1]The options will have an exercise price per share equal to the fair market value per ordinary share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").
- [F2]1/6 of the Ordinary Shares subject to the option vest on January 5, 2024, and the remainder vests in ten (10) equal quarterly installments following such date.
- [F3]The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents seven Ordinary Shares of the Issuer.